biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Chiesi

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 09, 2023 1:09pm

145 Views

Post# 35211496

RE:Chiesi

I gave a thumbs up to KayakerBC's post about the Chiesi/Amryt deal. I did so because I believe that over the next many years former Bioasis shareholders will be seeing medical advancements and deals like this being made by players that were involved with Bioasis and, ultimately, its demise.

I think it's going to be very hard to watch.

jd

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing